血

1 1995-1996 Hong Kong Cardiovascular Risk Factor Prevalence Study 2 6% 8% 66% 71% 34% 29% (International Hypertension Society of Guidelines) 3 (British Hypertension Society Guidelines) 4

1. 2. 2 3. 5 4. 7 5. 9 6. 7. 13 8. 16 17 Canadian Task Force 22 ( ) 24

III III Canadian Task Force (mmhg) 120 130 130-139 (mmhg) 80 85 85-89 140-159 140-149 160-179 180 90-99 90-94 100-109 110 140 140-149 90 90 WHO-ISH III

2.1 iii. 2.1.1 i. ii. 2.1.2 i. ii. iii. iv. v. a. b. 200mmHg 10 c. 10 2mmHg d. 2mmHg 2.1.3 i. ii. iii. 5mmHg (EMSD) 2.2 i. 5

ii. iii. iv. v. vi. vii. a. b. c. d. viii. 30 60 ix. 30mmHg x. 2mmHg xi. Korotkoff xii. Korotkoff Korotkoff xiii. 30

2.3 2.3.1 i. ii. 2mmHg iii. 2.2v iv. Korotkoff 2.2 xii v. a. 10 8-10mmHg b. 10% vi. 2.2 x vii. viii. 2.3.2 i. ii. iii. iv. v. 1 2 vi. vii. viii. ix.

3 3.1 i. ii. iii. iv. v. 3.2 i. ii. iii. / iv. v. vi. vii. viii. ix. x. xi. 3.3 i. BMI ii. iii. iv. v.

3.4 i. ii. iii. iv. v. 3.5

/ AN / / / / / / FBS -//+/++/+++ PVD

4.1 3,4,5 4.2 3,4,5,7 4,7 3,7 3,4,7 3,4,7 4.3 4,8 4.4 7,8 7,8 7,8 ACE 3 4 EL 8

/ RFT FBS

5. 3,9 ( ) 140 159 90 99 ( ) 160 179 100-109 ( ) 180 110 RF TOD / ACC** ( ) 140-159 160-179 180-219 90-99 ( ) 100-109 110-119 ( ) 220 120 140/90 140/90 1 2 ( ) 140/90 140/90

3 (III ) <140/90 ** RF= TOD= ACC= (RF) (TOD) (ACC) (1 3 ( ) 55 / 65 6.5 ( mmol/l (250mg/dl) ) (1.2-2.0mg/dl) ) ( > 2.0mg/dl 200

mol/l) 6. ( ) 3 6.1 6,10 6.1.1 (Canadian Task Force ) (US ) Task Force ) (I

6.2 6 6.2.1 (Canadian Task Force )(II-1 ) ( ) 6.2.2 ( ) 6 (Canadian Task Force )(II-2 ) 6.3 6.3.1 3 2 4 6.3.2 6 (Canadian Task Force ) ) (I 6.3.3 6.4 6.4.1 100mmol(5.8 ) 6 3, 9 (5 )( JNC ) 6.4.2 6.5 6.5.1 6 (Canadian Task Force 30 59 ) 6.6 6.6.1

30 40 3 4 6 (Canadian Task Force ) ) (II-2 7. 7.1 7.1.1-3 (I ) 4 7.1.2 (i) 3 (ii) 3 (iii) 2 4 (iv) 3

7.2 3,4,5,9,11,12 (I) - ( (I) ) a (Dihydropyridine ) (I) - () a ACE (I) -

N.B. (I) = I a 3 7.3 7.3.1 i. - ii. iii. iv. ACE (dihydropyridine ) - ACE v. - - 7.3.2. i ACE - ii 7.3.3 i ii iii - ACE

8. 8.1 (i) - > 130mmHg - - - - (ii) > 130mmHg + (iii) ( 20 mg stat 1 2 ) 220/120mmHg ( ) (iv) (a) (b) ( 140/90mmHg) ( ) 7 8.2 (i) (ii) (iii) (iv) (v) 30 20 ( ) (

3, 4, 13 (1) (2) (3) / (4) ( ) ( Phaechromocytoma ) (5) (6) / i. ( ) ii. iii. iv.

v. vi. vii. viii. ix. x. (7) i. (55 65 ) ii. iii. iv. v. vi. (8) ( 6.6.1 ) ( 3 ) (9) () (10) (1) ( ( ))) 5 5mmHg

(2) ( 3) (3) (4) A-V nipping silver wiring (5) (1) (2) ACE (3) / Eli Lily

(4) (5) /

14-24 (II 2 ) (1) : (2) 140/90mmHg 135/85mmHg (1) i. 140/90( ii. iii. iv. ) 140/90 v. vi.

(2) (3) 4 (4) (6) 2

( Canadian Task Force) 6 1. I II-1 II-2 II-3 III ( ) 2.

( ) (kg/m 2 ) <18.5 18.5 24.9 25 26 29.9 30 34.9 35 39.9 40

[] 1. 2. 3. 4. ) ( 5. ) ( 6. 7. ) ( 8. 9. 248 4 2891 5299 htpfp@yahoo.com

~ ~